Shipments of Duchenne Gene Therapy to Resume After FDA Review of Patient Death

(Medping TODAY) – The manufacturer of medicines Sarepta Therapeutics said that it would take the shipment of its gene therapy for certain patients, after a brief break requested by regulators. The FDA said that it has recommended to raise the take for young patients with Duchenne …